Growth Metrics

Microbot Medical (MBOT) EBIAT (2016)

Microbot Medical's EBIAT history spans 7 years, with the latest figure at -$4.2 million for Q3 2016.

  • For the quarter ending Q3 2016, EBIAT rose 55.95% year-over-year to -$4.2 million, compared with a TTM value of -$20.3 million through Sep 2016, up 46.08%, and an annual FY2020 reading of -$9.2 million, down 26.52% over the prior year.
  • EBIAT for Q3 2016 was -$4.2 million at Microbot Medical, down from $2.5 million in the prior quarter.
  • The five-year high for EBIAT was $2.5 million in Q2 2016, with the low at -$16.3 million in Q3 2012.
  • Average EBIAT over 5 years is -$7.1 million, with a median of -$7.6 million recorded in 2014.
  • Year-over-year, EBIAT tumbled 789.68% in 2013 and then skyrocketed 129.73% in 2016.
  • Tracing MBOT's EBIAT over 5 years: stood at -$2.8 million in 2012, then tumbled by 148.3% to -$6.8 million in 2013, then crashed by 47.61% to -$10.1 million in 2014, then grew by 11.36% to -$9.0 million in 2015, then surged by 52.59% to -$4.2 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's EBIAT are -$4.2 million (Q3 2016), $2.5 million (Q2 2016), and -$9.6 million (Q1 2016).